Our study for the first time uses genetically engineered human NSCs to study a specific genetic mutation on neoplastic transformation both in vitro and in intracranial tumour-initiating niches, and provided the proof-of-concept evidence that NSC is a most susceptible human adult stem cell type for PTEN-deficiency-induced oncogenic transformation. The gene discussed is PTEN; the disease is neoplasm.